Clifutinib Besylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Clifutinib Besylate, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML [Phase 1, Phase 2]